G-BA requested RWE collection for the second time – Fedratinib in myelofibrosis
Since 2020, the G-BA can request real-world evidence data collection in Germany. However, so far this was only implemented for one product,
Tag: RWE
IQWiG methods for RWE collection for products of same active ingredient class
Recently, I have written about RWE collection, that can be mandated by the G-BA as part of their benefit assessment. Now, the
IQWiG finds problems with the use of RWE in manufacturers’ dossiers
In this post, I’m following up on the key points on the real-world evidence (RWE) data collection in Germany with an IQWiG
What’s important to know about real-world evidence data collection in Germany?
In this post, I’ll summarise the key points on the real-world evidence data collection in Germany, that the G-BA can request since